Latest News & Features
Refine Search
Americas
Strong IP knowledge is one of four key factors to succeeding in the burgeoning US biosimilars market, according to an industry report. 15 May 2013
Americas
The US Supreme Court has decided unanimously in favour of agricultural company Monsanto in its patent battle against Indiana farmer Vernon Bowman. 14 May 2013
Big Pharma
The UK Court of Appeal has upheld the High Court’s decision that AstraZeneca’s patent for a sustained release formulation of anti-psychotic drug quetiapine is invalid. 10 May 2013
Americas
Pfizer has announced it will sell its erectile dysfunction pill Viagra online in an effort to counter the rising threat of bogus online pharmacies. 9 May 2013
Americas
Acura Pharmaceuticals has sued Ranbaxy Laboratories to keep it from releasing a generic version of its immediate release tablet formulation of painkiller Oxecta. 1 May 2013
Americas
Patent term restoration has been adopted by several jurisdictions, with varying success. Mexico faces several issues with sanitary authorisations and patent examination, so patent term restoration would be a viable remedy for patent holders. The TPP might enable this. 30 April 2013
Americas
James Monroe and Lawrence Ilag of Finnegan, Henderson, Farabow, Garrett & Dunner LLP analyse the impact of the US Court of Appeals for the Federal Circuit’s decision In re Kubin. 30 April 2013
Americas
While the global trend is towards a “more hostile IP environment” for pharmaceutical companies, Danish healthcare giant Novo Nordisk A/S continues to perform. LSIPR talks to Lars Kellberg, corporate vice president, about how it meets the challenges. 30 April 2013
Americas
Baker & McKenzie has hired Christian Alejandro López-Silva as head of its pharmaceutical and life sciences group in Mexico. 30 April 2013
Americas
Cyclacel Pharmaceuticals has entered into a definitive agreement to sell four of its patents related to the use of the romidepsin injection to Celgene Corporation. 30 April 2013